Molecular Analysis Improves FH Prognosis & Risk Stratification
Physician's Weekly
JUNE 24, 2025
Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy. The researchers published their findings before the National Lipid Association’s 2025 meeting, though not as part of it. Through testing that screened for 11 genetic markers, 67.9%
52 
Let's personalize your content